Organization Overview
Alternative names
darbepoetin alfa (aranesp) (4 trials)
docetaxel (taxotere) (1 trial)
eculizumab (Soliris) (2 trials)
enoxaparin (lovenox) (1 trial)
Acquired Immunodeficiency Syndrome (Phase 3)
Anemia (Phase 3)
Arthritis (Phase 3)
Arthritis, Psoriatic (Phase 3)
Arthritis, Rheumatoid (Phase 3)
Breast Neoplasms (Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Renal Cell (Phase 1)
Cholangitis (Phase 2)
Coinfection (Phase 3)
Hemoglobinuria (Phase 3)
Hemoglobinuria, Paroxysmal (Phase 3)
Hepatitis (Phase 3)
Hepatitis A (Phase 3)
Hepatitis C (Phase 3)
Hepatitis C, Chronic (Phase 3)
HIV Infections (Phase 3)
Immunologic Deficiency Syndromes (Phase 3)
Kidney Diseases (Phase 3)
Kidney Failure, Chronic (Phase 3)
Leukocytosis (Phase 1)
Liver Cirrhosis (Phase 2)
Liver Cirrhosis, Biliary (Phase 2)
Lung Neoplasms (Phase 3)
Lymphoma (Phase 3)
Lymphoma, B-Cell, Marginal Zone (Phase 3)
Lymphoma, Follicular (Phase 3)
Lymphoma, Non-Hodgkin (Phase 3)
Macular Degeneration (Phase 3)
Melanoma (Phase 2)
Multiple Sclerosis (Phase 3)
Multiple Sclerosis, Relapsing-Remitting (Phase 3)
Neutropenia (Phase 3)
Psoriasis (Phase 3)
Renal Insufficiency, Chronic (Phase 3)
Sclerosis (Phase 3)
Spondylitis (Phase 3)
Spondylitis, Ankylosing (Phase 3)
Thrombosis (Phase 3)
Uterine Cervical Neoplasms (Phase 3)
Venous Thrombosis (Phase 3)
Wet Macular Degeneration (Phase 1)